The Concord Biotech IPO has begun on 04-Aug-2023. It will close on 08-Aug-2023. The Total IPO Size is 1,551.00 Crore . The company set its IPO price is 741 Rs Per Share. Basically, there are three basic categories in Concord Biotech IPO Subscription 1) Qualified Institutional Buyers 2) Non-Institutional Investors 3) Retail.
Concord Biotech is established in 1984.
Concord Biotech is an biopharma company based on India.
They are one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2021.
They supplying to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India.
Concord Biotech IPO Promotor Shareholding
| Name of the Promoter | No. of Shares held | Percentage of total Shareholding | Average cost of Acquisition |
| Sudhir Vaid | 30,169,524 | 28.84% | 3.83 |
| Ankur Vaid | 586,520 | 0.56% | 2.27 |
| Total | 30,756,044 | 29.40% | – |
Concord Biotech IPO Date, Details & Price Band
The Concord Biotech IPO Price Band, IPO Dates, Market lot and other details mention in be below table.
| IPO Opening Dates | 04-Aug-2023 |
| IPO Closing Dates | 08-Aug-2023 |
| Price Band | 705-741 Rs |
| Fresh issue | NIL |
| OFS issue | 1,551.00 Crore |
| Total IPO size | 1,551.00 Crore |
| Minimum bid (lot size) | 20 Shares |
| Face Value | 1 INR Per Share |
| Issue Type | Book Built Issue IPO |
| Listing On | NSE, BSE |
Concord Biotech IPO Reservation
There are three basic category of Concord Biotech IPO Reservation, other mention in be below table.
| QIB Allocation | 50% |
| HNI Allocation | 15% |
| Retail Allocation | 35% |
Concord Biotech IPO Market Lot
The Concord Biotech IPO minimum market lot is 1 shares With 20 ₹ Amount per application.
| Lot | No of Shares | Amount | |
| Retail Minimum | 1 | 20 | 14,820 ₹ |
| Retail Maximum | 13 | 260 | 1,92,660 ₹ |
| S-HNI Minimum | 14 | 280 | 2,07,480 ₹ |
| S-HNI Maximum | 67 | 1,340 | 9,92,940 ₹ |
| B-HNI Maximum | 68 | 1,360 | 10,07,760 ₹ |
Restated Consolidated Financial Record of the three year (Amt. in Crore)
| Total Assets | Total Revenue | Profit After Tax | |
| 31-Mar-21 | 1,182.55 | 630.75 | 234.89 |
| 31-Mar-22 | 1,312.80 | 736.35 | 174.93 |
| 31-Mar-23 | 1,513.98 | 888.48 | 240.08 |
| EPS (₹) | NAV (₹) | RONW(%) | Borrowings (Crores) | |
| 31-Mar-21 | 22.45 | 95.53 | 26.55 | 86.35 |
| 31-Mar-22 | 16.72 | 105.45 | 16.64 | 60.59 |
| 31-Mar-23 | 22.95 | 123.31 | 20.06 | 31.24 |
Concord Biotech IPO GMP & Grey Market Premium
Concord Biotech IPO GMP Grey market premium has been started today. Check Latest Concord Biotech IPO GMP, Kostak Rates and Subject to Sauda Price here.
Concord Biotech IPO Prospectus
Concord Biotech IPO Prospectus Available on BSE and Sebi Website as well as on our Portal. Please click here to Download Concord Biotech IPO Prospectus.
| DRHP | Download |
| RHP | Download |
Concord Biotech IPO Reviews
Angel Broking – Update Soon
Choice Broking – Update Soon
Prabhudas Lilladher – Update Soon
Concord Biotech IPO Form Download
Concord Biotech IPO form Available on NSE, BSE Website as well as on our Portal. Please click here to Download Concord Biotech IPO forms.
Concord Biotech IPO Allotment Date & Details
| Allotment Date | 11-August-2023 |
| Initiation of refunds | 14-August-2023 |
| Transfer of shares to Demat accounts | 16-August-2023 |
| Listing Date | 17-August-2023 |
| Check Allotment Status | Click here |
Registrar of Concord Biotech
Link Intime India Private Limited
C 101, 247 Park
L.B.S Marg
Vikhroli (West), Mumbai 400 083
Maharashtra, India
Tel: +91 810 811 4949
E-mail:
[email protected]
Website: www.linkintime.co.in
Investor Grievance ID:
[email protected]
Contact Person: Shanti Gopalkrishnan
SEBI Registration Number:
INR000004058
Concord Biotech Contact Details
Concord Biotech Limited
1482-86,
Trasad Road Dholka,
Ahmedabad – 382225
Phone: 079-6813 8700
Email: [email protected]
Website: http://www.concordbiotech.com/
Concord Biotech IPO Lead Managers
Jefferies India Private Limited
Level 16, Express Towers
Nariman Point, Mumbai 400021
Maharashtra, India
Tel: +91 22 4356 6000
E-mail: [email protected]
Website: www.jefferies.com
Investor Grievance ID:
[email protected]
Contact Person: Suhani Bhareja
SEBI Registration Number: INM000011443
Citigroup Global Markets India Private Limited
1202, 12th Floor, First International Financial Centre,
G Block Bandra Kurla Complex, Bandra (East),
Mumbai 400098
Maharashtra, India
Tel: +91 22 6175 9999
E-mail: [email protected]
Website: http://www.online.citibank.co.in/rhtm/citigroupglobalscreen1.htm
Investor Grievance ID: [email protected]
Contact Person: Karan Singh Hundal
SEBI Registration Number: INM000010718
Kotak Mahindra Capital Company Limited
1st Floor, 27 BKC, Plot No. 27
G Block, Bandra Kurla Complex
Bandra (East), Mumbai 400 051
Maharashtra, India
Tel: +91 22 4336 0000
E-mail: [email protected]
Website: https://investmentbank.kotak.com
Investor Grievance ID: [email protected]
Contact Person: Ganesh Rane
SEBI Registration Number: INM000008704